Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if cognitive function improves in patients
converted from tacrolimus immediate release (TAC IR) to Envarsus XR® (tacrolimus extended
release) using an objective measure of cognition.